Plaque

Vinitaly International Academy Verona 2024: Berlucchi winery announces wine ambassador scholarship

Retrieved on: 
Monday, February 26, 2024
Supporter, Ambassador, Wine, Love, Franciacorta, Emotion, Education, Culture, Growth, Consortium, Plaque, Personality, VIA, Organization, Knowledge, Student, Tourism

VERONA, Italy, Feb. 26, 2024 /PRNewswire-PRWeb/ -- In April, Verona will host over 60 international wine professionals engaging in a comprehensive program encompassing five days of tastings, masterclasses, and seminars that compose the Vinitaly International Academy Italian Wine Ambassador Certification course. Nine distinguished wine consortiums and associations will contribute as official supporters of the program, while Berlucchi winery will return this year as an official educational supporter. Berlucchi's commitment this year includes the funding of a scholarship awarded to the most deserving candidate.

Key Points: 
  • The Vinitaly International Academy hosts the prestigious Italian Wine Ambassadors course in Verona from 4-8 April 2024.
  • VERONA, Italy, Feb. 26, 2024 /PRNewswire-PRWeb/ -- In April, Verona will host over 60 international wine professionals engaging in a comprehensive program encompassing five days of tastings, masterclasses, and seminars that compose the Vinitaly International Academy Italian Wine Ambassador Certification course.
  • Nine distinguished wine consortiums and associations will contribute as official supporters of the program, while Berlucchi winery will return this year as an official educational supporter.
  • This is why every Vinitaly International Academy project, with which we have been collaborating for some time, represents a real opportunity that we welcome with joy.

Healthy Foods Deliver Defense Against Cancer and Heart Disease

Retrieved on: 
Wednesday, February 21, 2024
Buffalo, Blood pressure, Diabetes, Breast cancer, Consumer, Effect, Copper, Research, Magnesium, Zinc, Cholesterol, Blood, Obesity, Mineral, Food, Vitamin, Weight loss, Glycemic, Prostate, Plant, Harvard University, Purdue University, Conditional sentence, Exercise, Plaque, Human body weight, Phytosterol, Niacin, Risk, Potassium, Vitamin E, Seed, Types of plant oils, Radiation, Olive oil, Health, Folate, University, Death, Nutrient, Fasting, Medicine, Artery, Physiology, Heart, Resveratrol, Food industry, Pinterest, Meal, Brain, Fats, HDL, Cancer, Randomized controlled trial, Dietary supplement

The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.

Key Points: 
  • The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.
  • According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed by cancer.
  • There are a number of factors that can increase the risk of developing heart disease, including high blood pressure, high cholesterol, obesity and diabetes .
  • Research shows that in addition to inhibiting colon, prostate and breast cancer cell growth, they can also protect against heart disease.

The College for Financial Planning®—a Kaplan Company Releases 2024 Survey of Financial Planning Professionals’ Views on Issues Ranging from Job Satisfaction to DEI to AI

Retrieved on: 
Monday, February 12, 2024
Education, Technology, Continuing, Artificial Intelligence, Training, University, Master of Science, DEI, Higher, Friends, Retirement, Plaque, Artificiality, Diversity, Equity, CFP, Certification, Family, Financial plan, Knowledge, Finance, Higher Learning Commission, Interview, Artificial intelligence, Nursing

The College for Financial Planning—a Kaplan Company has released its 2024 Survey of Trends , which explores the diverse experiences, interests, and viewpoints of professionals in the financial services industry*.

Key Points: 
  • The College for Financial Planning—a Kaplan Company has released its 2024 Survey of Trends , which explores the diverse experiences, interests, and viewpoints of professionals in the financial services industry*.
  • Those who believe the industry is doing too little say it is mainly because they still see a lack of representation within the industry.
  • "The College for Financial Planning is committed to providing professionals with the most up-to-date insights and knowledge and supporting their career growth at every stage.
  • From June through August 2023, 951 respondents completed the survey, although not all of them answered every question.

Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024

Retrieved on: 
Monday, February 12, 2024
SAN, Toxicology, Research, APP, Plaque, PPT1, Life, Haploinsufficiency, Science Advisory Board, CNS, GUSB, Patient, GALC, Gene, IDUA, Q&A, NAGLU, IND, AAV

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Jaya Biosciences, Inc. (“JayaBio” or “the Company”), a privately held early-stage life-sciences company developing CNS-directed gene therapies to address unmet needs in genetically defined neurodegeneration, reported non-clinical data at the 20th Annual WORLDSymposium™, a leading research conference on lysosomal diseases. During a late-breaking news platform presentation, Jaya Biosciences’ scientific founder, Prof. Mark Sands, reported preliminary human genetic analysis suggesting that heterozygous loss-of-function mutations in lysosomal enzyme genes are enriched in Alzheimer’s patients, as well as preclinical efficacy results in the animal model of Alzheimer’s disease (AD) for JB111, the Company’s lead therapy.

Key Points: 
  • “We are thrilled to showcase a new paradigm for the treatment of genetically defined neurodegeneration at the 20th WORLDSymposium™,” said Pawel Krysiak, President and CEO of JayaBio.
  • “The preclinical data we presented demonstrate a tremendous promise of targeting PPT1 haploinsufficiency in Alzheimer’s disease.
  • Heterozygosity of five different lysosomal enzyme genes (PPT1, NAGLU, GALC, IDUA, GUSB) significantly affects amyloid precursor protein (APP) processing and favors pro-amyloidogenic pathway.
  • CNS-directed, AAV-mediated gene therapy significantly increases the life span and improves cognitive function of 5xFAD/PPT1+/- mice.

Cleerly® Announces CERTAIN Multicenter Clinical Trial Results

Retrieved on: 
Thursday, February 8, 2024
Health, Clinical Trials, Cardiology, Other Health, Drug, Ischemia, MD, American College, Derivation, Cole, Detection, Medicine, Intelligence, Artificial intelligence, Coronary ischemia, Science, Atherosclerosis, Society, CCTA, Myocardial perfusion imaging, PMID, Plaque, SPECT, PET, FDA, Adenosine, American Journal of Roentgenology, Diagnosis, Patient, Stenosis, Moyamoya disease, Validation, Splenic infarction, Physician, Health literacy, Journal, Coronary artery disease, Coronary, Medical imaging

These results underscore the strong and positive effect of the Cleerly products on clinical utility for patients with suspected coronary artery disease.

Key Points: 
  • These results underscore the strong and positive effect of the Cleerly products on clinical utility for patients with suspected coronary artery disease.
  • In all multicenter and single clinical studies performed to date, Cleerly’s products have consistently demonstrated robust clinical utility, including higher diagnostic accuracy and stronger prognostic risk stratification over such historical tests as nuclear SPECT stress testing and FFRCT2-7.
  • Cleerly’s approach is grounded in science, based on over 10 million images from over 40,000 patients gathered over a 15-year-period in landmark, multi-center clinical trials.
  • Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.

Little Dogs Have Smaller Teeth, But Bigger Teeth Problems

Retrieved on: 
Wednesday, February 7, 2024
Brachycephaly, Life, Human, Tooth loss, Plaque, Dental care, Dog, Microstomia, Specialty, Periodontal disease, Risk, Gingivitis, Dentistry

AUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ -- National Pet Dental Health Month is underway and Thrive Pet Healthcare, a leading veterinary healthcare network with more than 380 locations in 37 states across the U.S., is spotlighting a concerning trend – small dogs tend to develop dental problems more rapidly and at younger ages than bigger dogs.

Key Points: 
  • Small dogs tend to develop dental problems more rapidly and at younger ages than bigger dogs.
  • "Their compact mouths, heads and faces, along with other genetic features, predispose them to rapid tartar buildup, plaque and gingivitis more than larger dogs."
  • Brachycephalic or flat-faced dog breeds like Boston terriers and pugs often experience crowded or misaligned teeth, leading to early onset periodontal disease.
  • No matter a dog's size, signs of dental problems may not be obvious to their owner.

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Retrieved on: 
Thursday, February 1, 2024
Health Technology, Technology, Cannabis, Pharmaceutical, Seniors, Artificial Intelligence, Natural Resources, Clinical Trials, Other Technology, Vitamins, Supplements, Biotechnology, Science, Other Science, Consumer, Research, Health, APP, Anxiety, Agitation, Peptide, Plaque, Machine learning, IGC, Artificial intelligence, Mouse, Dementia, Amyloid, Toxicology, Movement

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer's disease.

Key Points: 
  • IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer's disease.
  • Previously disclosed results demonstrate that TGR-63 may successfully alleviate plaque burden in Alzheimer's cell lines and animal models.
  • In line with IGC Pharma's artificial intelligence and machine learning ("AI/ML") initiatives, we plan to leverage cutting-edge AI/ML tools for studying TGR-63's toxicology and protein interactions.
  • The results from these multiple tests indicate that TGR-63 treatment helped normalize emotional and behavioral responses in our Alzheimer's mouse model, reinforcing its potential as a promising treatment.

White Castle Inducts 11 Loyal Cravers and, for the First Time Ever, One Extraordinary Craver Community Into Its Cravers Hall of Fame

Retrieved on: 
Thursday, February 1, 2024
WBNS, Magic, Family, Plaque, Slider, News, Flower, Orlando, Florida, Friends, Craver, Part, Ice, Grandparent, My Girl, Ohio State University, American Birkebeiner, Love, The White Castle, Social media, Crave, Christmas Eve, CBS, Hall, Student, White, Fast food

COLUMBUS, Ohio, Feb. 1, 2024 /PRNewswire/ -- There's a new group of royalty inside White Castle's walls. On Wednesday, the beloved fast-food pioneer and popular consumer-packaged goods business announced the 11 newest members of its Cravers Hall of Fame, an exclusive club that White Castle created in 2001 to recognize its most zealous fans. For the first time ever, the list includes an entire city of Cravers!

Key Points: 
  • Each year, hundreds of Cravers submit their White Castle stories in hopes of being chosen for the Cravers Hall of Fame.
  • During subsequent meetings at White Castle, Dick often talked about the role of White Castle in his family's life.
  • White Castle created this title in 2002 to recognize public figures, celebrities and pop icons who have publicly expressed their love of White Castle.
  • You may have seen the White Castle Town Crier make an appearance at the groundbreaking for the Orlando White Castle, in a social media video

Steel Tube Institute Launches Inaugural Conduit Photo Contest

Retrieved on: 
Tuesday, January 30, 2024
Calendar, Plaque, STI

CHICAGO, Jan. 30, 2024 /PRNewswire/ -- The Steel Tube Institute (STI), an organization that brings together producers in the steel industry to advance the use of steel tubing, announced its inaugural steel conduit photo contest with the goal of bringing together the electrical community, showcasing the craftmanship that is necessary for steel conduit installation and ultimately highlight steel conduit's role in America's electrical raceways.

Key Points: 
  • CHICAGO, Jan. 30, 2024 /PRNewswire/ -- The Steel Tube Institute (STI), an organization that brings together producers in the steel industry to advance the use of steel tubing, announced its inaugural steel conduit photo contest with the goal of bringing together the electrical community, showcasing the craftmanship that is necessary for steel conduit installation and ultimately highlight steel conduit's role in America's electrical raceways.
  • "The subtle art of bending and installing conduit represents the true craftsmanship of the electrical trade," says Dale Crawford, executive director of Steel Tube Institute.
  • Entries for the 2024 Steel Tube Institute Conduit Photo Contest will open on February 1st, 2024, and close in mid-October 2024.
  • To learn more about the Steel Tube Institute , its mission and vision, visit www.SteelTubeInstitute.org .

Eating leafy greens could be better for oral health than using mouthwash

Retrieved on: 
Tuesday, January 30, 2024
Diabetes, Swelling, Xerostomia, Mouth, Patient, Tooth decay, Oral hygiene, Dementia, Chlorhexidine, Research, Magnetic resonance, Plaque, Vitamin, Periodontal disease, Smoking, Diet, Gingivitis, Rheumatoid arthritis, Athlete, Nitrate, Tooth loss, Nitric oxide, Cancer, Beetroot, Risk, Immune system, Bacteria, Dental plaque, Carbohydrate, Disease, Vegetable, Pregnancy, Thumb, Inflammation, Bleeding, Red, Lettuce, Mineral, Exercise, News, Mouthwash, Fungus, Dentistry, Cardiovascular disease, Blood pressure, Antioxidant

These treatments have side effects, such as dry mouth, the development of antimicrobial resistance and increased blood pressure.

Key Points: 
  • These treatments have side effects, such as dry mouth, the development of antimicrobial resistance and increased blood pressure.
  • But research has indicated that a molecule called nitrate, which is found in leafy green vegetables, has fewer side effects and offers greater benefits for oral health.
  • Periodontitis is a more advanced form of gum disease, causing damage to the soft tissues and bones supporting the teeth.

Leafy greens may be the secret

  • Leafy greens and root vegetables are bursting with vitamins, minerals, and antioxidants – and it’s no secret that a diet consisting of these vegetables is crucial for maintaining a healthy weight, boosting the immune system, and preventing heart disease, cancer and diabetes.
  • The multiple health benefits of leafy greens are partly because spinach, lettuce and beetroots are brimming with nitrate, which can be reduced to nitric oxide by nitrate-reducing bacteria inside the mouth.
  • However, in the mouth, it helps to prevent the overgrowth of bad bacteria and reduces oral acidity, both of which can cause gum disease and tooth decay.
  • Antimicrobial resistance is a global health concern, predicted to cause 10 million deaths yearly by the year 2050.


In contrast, dietary nitrate is more targeted. Nitrate eliminates disease-associated bacteria, reduces oral acidity and creates a balanced oral microbiome. The oral microbiome refers to all the microorganisms in the mouth. Nitrate offers exciting potential as an oral health prebiotic, which can be used to prevent disease onset or limit disease progression.

How many leafy greens for pearly whites?

  • As a rule of thumb, a generous helping of spinach, kale or beetroot at mealtimes contains about 6-10 mmol of nitrate and offers immediate health benefits.
  • For example, consuming lettuce juice for two weeks reduced gum inflammation and increased healthy bacteria levels in patients with gum disease.


Mia Cousins Burleigh has previously received funding from The Royal Society of Edinburgh. Siobhan Paula Moran does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.